| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |